![]() |
![]() This is the first in a series on pricing in a softening market. Here we focus on the growing gap between technical price and market price. Later articles will dive into thoughts on judgement and governance. As rates soften across many lines in the London Market, it is worth stepping back and asking a simple question: what role should technical pricing play when the softening market is driving the price? Soft markets are not new. What feels different today is the amount of investment in pricing transformation. |
By Laura Hobern, Partner, LCP Many firms have more sophisticated models, better tools and more data than ever before. This is positive, but it can also create a false sense of comfort. Models may appear robust, yet they are often still built on limited data, judgemental assumptions and a degree of uncertainty that doesn’t show up in the final figure. Modelling technical price alone is not enough; it needs to sit within a wider pricing framework that recognises both what models can tell us and what they cannot. Too much reliance on technical pricing at an individual risk level can be misleading. However, dismissing technical pricing altogether is far more dangerous. Technical price and market price
The technical price is the actuarial view of what a risk should cost. It reflects expected losses, expenses, capital requirements and target returns based on available data and assumptions. Its purpose is to anchor pricing decisions to a consistent, informed view of risk.
The market price, by contrast, is shaped by competition. It reflects available capacity, broker influence and growth targets. These forces intensify as capacity expands and competition increases. A gap between technical and market price is inevitable. What matters is not the existence of the gap, but how well you understand and manage it. Softening markets hide risk in plain sight
In a softening market, market prices usually move faster than risk. Competitive pressure drives rate reductions quickly, while loss trends can take years to emerge.
For example, a portfolio may show favourable loss ratios this year because it is still benefiting from last year’s pricing. Meanwhile, new business is being written at thinner margins. On paper, performance looks healthy. In reality, the risk profile may already be shifting. This claims lag can lead to a false sense of comfort. By the time deterioration shows up in the numbers, the portfolio has already changed shape. Technical pricing remains critical in this environment. It gives you a consistent reference point to the underlying risk when market signals become unreliable. It is not a price that must always be achieved, but a way of understanding how far the business is moving away from its risk-based view and whether that movement is deliberate. Without that anchor, under-pricing can build gradually. When correction comes, it is often sharper and more painful than it needed to be. Technical pricing as a diagnostic tool
Technical pricing is most useful as a diagnosis tool rather than a strict rulebook. Used well, it provides insight into portfolio health, risk drift, and future volatility.
If you treat it as a reference point, it becomes easier to see what is actually happening. For example, are you winning new business based on quality and risk selection, or on price concessions? Are certain brokers consistently outside technical levels? Are technical price overrides becoming routine rather than occasional? Problems tend to arise when models are overridden routinely without understanding why. Over time, those adjustments can become systematic, effectively changing your assumptions without scrutiny or validation. These patterns matter more than any single deal. On the other hand, insisting on achieving the technical price in all circumstances is not the answer. Doing so can reduce competitiveness, encourage model manipulation, and reinforce the perception that actuarial pricing is disconnected from market reality. The aim is not perfection but, rather, informed decision making. In practical terms, this means tracking how far and how often pricing departs from technical levels, asking for a clear rationale when deviations persist, and using model outputs to support discussion rather than to restrict decision making. Many actuarial teams have strong technical capability, but less clarity on how to turn those outputs into insight for the business. What to monitor before results deteriorate
By the time loss ratios deteriorate, the damage has already been done. In a soft market, you need to watch leading indicators carefully.
That does not mean building a long list of metrics. A small set of focused measures is often more effective. For example: how rate change compares to changes in technical adequacy, how often (and by how much) technical prices are overridden, where win rates are increasing, and whether technical inadequacy is concentrated in certain brokers or segments. In practice, this can be challenging. Data often exists but it sits in different place, and discussions tend to focus on approvals rather than what the decisions add up to over time. Even firms with sophisticated models can struggle to interpret divergence, translate outputs into insight and design management information that prompts timely action. Practical steps you can take straight away include:
Building a small set of leading indicators reviewed regularly at senior level
Focusing discussions on patterns and trends rather than individual deals
Escalating emerging issues early rather than waiting for financial performance to force action.
Closing thoughts
While divergence between technical and market price is an unavoidable part of operating in a soft market, the risk often lies not in the gap itself, but in failing to monitor, understand and manage it.
Used properly, technical pricing does not prevent commercial decisions. Rather, it ensures that they are well-informed and deliberate. In the next article in this series, we look at where technical pricing ends and judgement begins, and who decides how far to follow the market. |
|
|
|
| Portfolio Actuary | ||
| London - £140,000 Per Annum | ||
| Deputy Head of Capital | ||
| London - £140,000 Per Annum | ||
| Senior Pricing & Portfolio Management... | ||
| London - £150,000 Per Annum | ||
| Pricing Transformation Lead | ||
| London - £85,000 Per Annum | ||
| Lead Capital Actuary | ||
| London - £150,000 Per Annum | ||
| Take the lead on capital oversight | ||
| London / hybrid 2 days p/w office-based - Negotiable | ||
| Be at the forefront of creative GI co... | ||
| London/hybrid 2-3dpw office-based - Negotiable | ||
| Remote Market and Credit Risk Calibra... | ||
| Remote - Negotiable | ||
| Contact us about a Capital Contract i... | ||
| London / hybrid 2 days p/w office-based - Negotiable | ||
| Head of Insurance Risk | ||
| London - £160,000 Per Annum | ||
| Director - Pensions Risk Transfer (PRT) | ||
| London, Midlands, North West - hybrid working 2dpw in the office - Negotiable | ||
| Dip a toe into public sector work wit... | ||
| Flex / hybrid 2 days p/w office-based - Negotiable | ||
| P&C Consultant | ||
| London / hybrid 3dpw office-based - Negotiable | ||
| Take the lead client-facing projects ... | ||
| Various locations - Negotiable | ||
| Choose Life! Choose a major global co... | ||
| Various locations - Negotiable | ||
| Actuarial skillset? Apply now for Snr... | ||
| South East / hybrid with travel requirements - Negotiable | ||
| Financial Risk Leader - ALM Oversight | ||
| Flex / hybrid - Negotiable | ||
| Be the very model of a modern Capital... | ||
| London - Negotiable | ||
| Pensions Actuary seeking a high-impac... | ||
| London or Scotland / hybrid 3dpw office-based - Negotiable | ||
| Great opportunity for Pensions Actuar... | ||
| London or Scotland / hybrid 3dpw office-based - Negotiable | ||
Be the first to contribute to our definitive actuarial reference forum. Built by actuaries for actuaries.